ConductScience.org, home

Paper27928014

Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.

Zoubchenok D and 7 others. J Virol, 2017. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins. Papers, record 27928014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27928014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
PubMed
Journal
J Virol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2022-09-16
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zoubchenok DDaria
2Veillette MMaxime
3Prévost JJérémie
4Sanders-Buell EEric
5Wagh KKshitij
6Korber BBette
7Chenine ALAgnès L
8Finzi AAndrés

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD4 AntigensMajor topic
HIV Envelope Protein gp120Major topic
HIV InfectionsMajor topic
HIV-1Major topic
HistidineMajor topic
Amino Acid Substitution
Cell Line
Humans
Mutation
Phylogeny
Protein Binding
Virus Attachment
Virus Internalization

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI131251NIAID NIH HHSUnited StatesP01AI131251PubMedNIH RePORTER
UM1 AI100645NIAID NIH HHSUnited StatesUM1AI100645PubMed and NIHNIH RePORTER
352417CIHRCanadaPubMedPubMed
291485CIHRCanadaPubMedPubMed

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120949103Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.PLoS Comput Biol2010https://conductscience.org/library/papers/20949103PubMed
210766634HIV-1 nomenclature proposal.Science2000https://conductscience.org/library/papers/10766634PubMed
37541846Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.J Virol1995https://conductscience.org/library/papers/7541846PubMed
47520095Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.J Virol1994https://conductscience.org/library/papers/7520095PubMed
59284369Recombination in HIV: an important viral evolutionary strategy.Emerg Infect Dis1997https://conductscience.org/library/papers/9284369PubMed
618971501The challenge of HIV-1 subtype diversity.N Engl J Med2008https://conductscience.org/library/papers/18971501PubMed
722696649Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding.J Virol2012https://conductscience.org/library/papers/22696649PubMed
87543586Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.J Virol1995https://conductscience.org/library/papers/7543586PubMed
99525605Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.J Virol1998https://conductscience.org/library/papers/9525605PubMed
1027247400Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27247400PubMed
1120227370Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.Mol Cell2010https://conductscience.org/library/papers/20227370PubMed
1212151398Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis.J Biol Chem2002https://conductscience.org/library/papers/12151398PubMed
139032394Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239.J Virol1997https://conductscience.org/library/papers/9032394PubMed
1417363674Founder effects in the assessment of HIV polymorphisms and HLA allele associations.Science2007https://conductscience.org/library/papers/17363674PubMed
1516622870Global epidemiology of HIV.J Med Virol2006https://conductscience.org/library/papers/16622870PubMed
161700865Retroviral recombination and reverse transcription.Science1990https://conductscience.org/library/papers/1700865PubMed
1711371682Viral load differences in early infection with two HIV-1 subtypes.AIDS2001https://conductscience.org/library/papers/11371682PubMed
1823255784The highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions.J Virol2013https://conductscience.org/library/papers/23255784PubMed
1920331894The role of recombination in the emergence of a complex and dynamic HIV epidemic.Retrovirology2010https://conductscience.org/library/papers/20331894PubMed
207816094Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.Nature1995https://conductscience.org/library/papers/7816094PubMed

See all 58 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
41363844Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity.J Virol2026https://conductscience.org/library/papers/41363844PubMed
41058708HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strains.Front Immunol2025https://conductscience.org/library/papers/41058708PubMed
40145736A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120.J Virol2025https://conductscience.org/library/papers/40145736PubMed
38169306Implications of the 375W mutation for HIV-1 tropism and vaccine development.J Virol2024https://conductscience.org/library/papers/38169306PubMed
37888980V3 tip determinants of susceptibility to inhibition by CD4-mimetic compounds in natural clade A human immunodeficiency virus (HIV-1) envelope glycoproteins.J Virol2023https://conductscience.org/library/papers/37888980PubMed
37872202Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir.Nat Commun2023https://conductscience.org/library/papers/37872202PubMed
37243271Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC.Viruses2023https://conductscience.org/library/papers/37243271PubMed
36958337Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120.Cell Chem Biol2023https://conductscience.org/library/papers/36958337PubMed
36749076Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.J Virol2023https://conductscience.org/library/papers/36749076PubMed
35980207Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.J Virol2022https://conductscience.org/library/papers/35980207PubMed
34586863Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV Infection.J Virol2021https://conductscience.org/library/papers/34586863PubMed
33101312Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.Front Immunol2020https://conductscience.org/library/papers/33101312PubMed
32769632Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors.Curr Opin HIV AIDS2020https://conductscience.org/library/papers/32769632PubMed
32457241The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.mBio2020https://conductscience.org/library/papers/32457241PubMed
31776278Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency.J Virol2020https://conductscience.org/library/papers/31776278PubMed
31554684A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity.J Virol2019https://conductscience.org/library/papers/31554684PubMed
29758076High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses.PLoS One2018https://conductscience.org/library/papers/29758076PubMed
29020646HIV-1 subtype CRF01_AE and B differ in utilization of low levels of CCR5, Maraviroc susceptibility and potential N-glycosylation sites.Virology2017https://conductscience.org/library/papers/29020646PubMed
28893275Unlocking HIV-1 Env: implications for antibody attack.AIDS Res Ther2017https://conductscience.org/library/papers/28893275PubMed
28100618Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.J Virol2017https://conductscience.org/library/papers/28100618PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27928014

GET https://conductscience.org/api/papers/v1/27928014/references?page=2